In addition, prognostic value WT1 expression was demonstrated in CML (chronic myelogenous leukemia), in which a high level of WT1 expression is detected in CML patients with relapse while remaining low in the patients with complete remission [18, 25]. This evidence concerns the gene WT1 and chronic myelogenous leukemia, BCR-ABL1 positive.